I totally understand the cynicism and frustration with these stocks if you have been around here for any length of time. It does get old waiting and speculating on the future events. The staffing of the advisory board looks awesome, the CFO and new president are well creditialed, but into the vortex they go it seems and its biz as usual. Frustrating to say the least.
But the status is the best its every been for Regen. There should be news forthcoming soon on bigger developments given the Regen's partnership with NCATS(NIH), which will radically speed up any timelines to understand potential for NR2F6, which will most likely have implications for ENTB, upcoming human trials for HemaXellerate, status on DCellVax, Diffron C, pipeline, funding and other.
Been here this long may as well ride it out now.
IMO. GL.
